prepandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted) novartis vaccines and diagnostics
novartis vaccines and diagnostics s.r.l. - influenzavirusoverfladeantigener (hæmagglutinin og neuraminidase) af stamme a / viet nam / 1194/2004 (h5n1) - influenza, human; immunization; disease outbreaks - vacciner - aktiv immunisering mod h5n1-subtype af influenza a-virus. , , this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of the vaccine containing a/vietnam/1194/2004 (h5n1)-like strain. , , prepandemic influenza vaccine (h5n1) novartis vaccines and diagnostic should be used in accordance with official recommendations.
certican 0,25 mg dispergible tabletter
novartis healthcare a/s - everolimus - dispergible tabletter - 0,25 mg
certican 0,5 mg tabletter
novartis healthcare a/s - everolimus - tabletter - 0,5 mg
certican 0,75 mg tabletter
novartis healthcare a/s - everolimus - tabletter - 0,75 mg
ciflox 10+2 mg/ml øredråber, suspension
novartis healthcare a/s - ciprofloxacinhydrochlorid, vandfrit, hydrocortison - øredråber, suspension - 10+2 mg/ml
ciloxan 3 mg/ml øjendråber, opløsning
novartis healthcare a/s - ciprofloxacinhydrochlorid, vandfrit - øjendråber, opløsning - 3 mg/ml
desferal 500 mg pulver til injektions-/infusionsvæske, opløsning
novartis healthcare a/s - deferoxaminmesilat - pulver til injektions-/infusionsvæske, opløsning - 500 mg
lescol depot 80 mg depottabletter
novartis healthcare a/s - fluvastatinnatrium - depottabletter - 80 mg
lioresal 0,5 mg/ml injektions-/infusionsvæske, opløsning
novartis healthcare a/s - baclofen - injektions-/infusionsvæske, opløsning - 0,5 mg/ml
lioresal 2 mg/ml injektions-/infusionsvæske, opløsning
novartis healthcare a/s - baclofen - injektions-/infusionsvæske, opløsning - 2 mg/ml